A Toby Prevost

14.3k total citations · 1 hit paper
236 papers, 9.3k citations indexed

About

A Toby Prevost is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A Toby Prevost has authored 236 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Public Health, Environmental and Occupational Health, 36 papers in Oncology and 31 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A Toby Prevost's work include Behavioral Health and Interventions (18 papers), Retinal Imaging and Analysis (18 papers) and Retinal Diseases and Treatments (18 papers). A Toby Prevost is often cited by papers focused on Behavioral Health and Interventions (18 papers), Retinal Imaging and Analysis (18 papers) and Retinal Diseases and Treatments (18 papers). A Toby Prevost collaborates with scholars based in United Kingdom, France and United States. A Toby Prevost's co-authors include Stephen Sutton, Martin Gulliford, Simon J. Griffin, Margaret J. Whichelow, Theresa M. Marteau, Ann Louise Kinmonth, David French, Gareth J Hollands, Helen Booth and Jon Emery and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

A Toby Prevost

228 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis

2016 338 citations Gareth J Hollands, David French et al. profile →

Peers

Countries citing papers authored by A Toby Prevost

Since Specialization

Citations

This map shows the geographic impact of A Toby Prevost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Toby Prevost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Toby Prevost more than expected).

Fields of papers citing papers by A Toby Prevost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Toby Prevost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Toby Prevost. The network helps show where A Toby Prevost may publish in the future.

Co-authorship network of co-authors of A Toby Prevost

This figure shows the co-authorship network connecting the top 25 collaborators of A Toby Prevost. A scholar is included among the top collaborators of A Toby Prevost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Toby Prevost. A Toby Prevost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nurse-led palliative care for multidrug-resistant tuberculosis: a parallel, single-blind, pragmatic, randomised controlled trial in Uganda 2025 ·The Lancet Global Health ·(unknown), Kennedy Nkhoma, Eve Namisango, Matthew Maddocks, Julia Downing, A Toby Prevost, (unknown), Richard Harding	1
2	Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trial 2024 ·BMJ Open ·(unknown), Ethaar El‐Emir, (unknown), Marko Topalovic, Rachael A Evans, Richard Russell, Karl Sylvester, (unknown), Anthony Paulo Sunjaya, David A. Scott, A Toby Prevost, Jennifer Harvey, Stephanie Taylor, Nicholas S Hopkinson, Samantha S.C. Kon, Ian Jarrold, (unknown), Winston Banya, William D‐C Man	2
3	A smoking cessation smartphone app that delivers real-time ‘context aware’ behavioural support: the Quit Sense feasibility RCT 2024 ·SHILAP Revista de lepidopterología ·Felix Naughton, (unknown), Chloë Brown, Kelly Grant, Caitlin Notley, (unknown), (unknown), Cecilia Mascolo, Tim Coleman, Garry Barton, Lee Shepstone, A Toby Prevost, Stephen Sutton, David Crane, Felix Greaves, Juliet High	2
4	Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes 2024 ·Thorax ·David Antcliffe, Yuxin Mi, Shalini Santhakumaran, Katie L. Burnham, A Toby Prevost, (unknown), (unknown), (unknown), Farah Al-Beidh, Paula Hutton, Stuart McKechnie, Emma E. Davenport, Charles Hinds, Cecilia O’Kane, Daniel F. McAuley, Manu Shankar‐Hari, Anthony Gordon, Julian C. Knight	9
5	Integration of palliative rehabilitation in cancer care: a multinational mixed method study 2024 ·BMC Palliative Care ·Guro B. Stene, May Aasebø Hauken, (unknown), (unknown), (unknown), Joanne Bayly, Augusto Caraceni, Stefania Costi, (unknown), Mai‐Britt Guldin, Barry Laird, (unknown), Matthew Maddocks, A Toby Prevost, (unknown), Line Oldervoll	1
6	Spirometry services in England post-pandemic and the potential role of AI support software: a qualitative study of challenges and opportunities 2023 ·British Journal of General Practice ·(unknown), Stephanie Taylor, Marko Topalovic, Richard Russell, Rachael A Evans, (unknown), (unknown), Anthony Paulo Sunjaya, David A. Scott, A Toby Prevost, (unknown), Jennifer Harvey, Nicholas S Hopkinson, Samantha S.C. Kon, Suhani Patel, Ian Jarrold, (unknown), William D‐C Man, Anne Hutchinson	12
7	Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs 2021 ·SHILAP Revista de lepidopterología ·Manu Shankar‐Hari, Shalini Santhakumaran, A Toby Prevost, (unknown), (unknown), (unknown), Carolyn S. Calfee, Kevin Delucchi, Pratik Sinha, Michael A. Matthay, Jonathan Hackett, Clíona McDowell, John G. Laffey, Anthony Gordon, Cecilia O’Kane, Daniel F. McAuley	17
8	Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study 2021 ·PharmacoEconomics ·Becky Pennington, Abualbishr Alshreef, Laura Flight, (unknown), Edith Poku, Philip Hykin, Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos, Caroline Murphy, Joanna Kelly, Yit C. Yang, Andrew Lotery, (unknown), John Brazier	6
9	Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT 2021 ·Health Technology Assessment ·Philip Hykin, A Toby Prevost, Sobha Sivaprasad, Joana C. Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Becky Pennington, Barry Hounsome, (unknown), (unknown), Edith Poku, Yit C. Yang, Simon Harding, Andrew Lotery, Usha Chakravarthy, John Brazier	12
10	Improving the Interpretation of Afternoon Cortisol Levels and SSTs to Prevent Misdiagnosis of Adrenal Insufficiency 2021 ·Journal of the Endocrine Society ·(unknown), (unknown), A Toby Prevost, Tricia Tan, Karim Meeran, Sirazum Choudhury	5
11	Randomised controlled trial of a just-in-time adaptive intervention (JITAI) smoking cessation smartphone app: the Quit Sense feasibility trial protocol 2021 ·BMJ Open ·Felix Naughton, Chloë Brown, Juliet High, Caitlin Notley, Cecilia Mascolo, Tim Coleman, Garry Barton, Lee Shepstone, Stephen Sutton, A Toby Prevost, David Crane, Felix Greaves, (unknown)	10
12	A Highly Tailored Text and Voice Messaging Intervention to Improve Medication Adherence in Patients With Either or Both Hypertension and Type 2 Diabetes in a UK Primary Care Setting: Feasibility Randomized Controlled Trial of Clinical Effectiveness 2020 ·Journal of Medical Internet Research ·Aikaterini Kassavou, (unknown), James Brimicombe, Simon Edwards, Efthalia Massou, A Toby Prevost, Simon J. Griffin, Stephen Sutton	32
13	Assessment of the Effectiveness and Cost-Effectiveness of Tailored Web- and Text-Based Smoking Cessation Support in Primary Care (iQuit in Practice II): Protocol for a Randomized Controlled Trial 2020 ·JMIR Research Protocols ·(unknown), Felix Naughton, Melanie Sloan, (unknown), James Brimicombe, A Toby Prevost, Ed Wilson, Tim Coleman, Stephen Sutton	3
14	Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study 2019 ·Health Technology Assessment ·Martin Gulliford, Dorota Juszczyk, A Toby Prevost, (unknown), Lisa McDermott, (unknown), Mark Wright, Robin Fox, Alastair D Hay, Paul Little, Michael Moore, Lucy Yardley, Mark Ashworth, Judith Charlton	24
15	A systematic review identifying common data items in neonatal trials and assessing their completeness in routinely recorded United Kingdom national neonatal data 2019 ·Trials ·Sena Jawad, Neena Modi, A Toby Prevost, Chris Gale	5
16	Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions 2010 ·Statistical Methods in Medical Research ·(unknown), Michael J. Campbell, Sandra Eldridge, Amanda Farrin, (unknown), Sabine Müller, Rafael Perera, T. J. Peters, A Toby Prevost, Greta Rait	31
17	Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours 2010 ·Cochrane Database of Systematic Reviews ·Theresa M. Marteau, David French, Simon J. Griffin, A Toby Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands	202
18	Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma 2009 ·Clinical Cancer Research ·(unknown), Sarah R. Kingsbury, Slavica Tudzarova, Hye-Kyung Hong, Marco Loddo, Mohammed Rashid, Sara Rodríguez‐Acebes, A Toby Prevost, Jonathan A. Ledermann, Kai Stoeber, Gareth Williams	59
19	Explaining Behavior Change after Genetic Testing: The Problem of Collinearity between Test Results and Risk Estimates 2008 ·Genetic Testing ·Thomas Fanshawe, A Toby Prevost, J. Scott Roberts, Robert C. Green, David Armstrong, Theresa M. Marteau	20
20	Influences on the variation in prevalence of type 2 diabetes between general practices: practice, patient or socioeconomic factors? 2003 ·PubMed ·David L Whitford, Simon J. Griffin, A Toby Prevost	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact